Xi'an, China

Chenguan Liang

This inventor holds 1 USPTO granted patent. Top assignee: Shaanxi University of Science and Technology. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chenguan Liang: Innovator in Medicinal Chemistry

Introduction

Chenguan Liang is a prominent inventor based in Xi'an, China. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative research and development of pharmaceutical compounds. His work focuses on creating effective solutions for combating pathogenic microorganisms.

Latest Patents

Chenguan Liang holds a patent for a pleuromutilin derivative containing a thiazole-pyridine benzyl quaternary ammonium salt side chain. This invention includes a preparation method and its use, which is crucial in the development of new antibacterial and anti-mycoplasma drugs. The synthesis method he developed utilizes easily available raw materials, ensuring simple operation and high product yield, making it suitable for industrial production. The results from in vitro pharmacological experiments indicate that this pleuromutilin derivative exhibits excellent antibacterial properties and good solubility, highlighting its potential value in pharmaceutical applications.

Career Highlights

Chenguan Liang is affiliated with the Shaanxi University of Science and Technology, where he continues to advance his research in medicinal chemistry. His dedication to innovation has led to the successful development of compounds that can significantly impact the medical field.

Collaborations

Chenguan Liang has collaborated with notable colleagues, including Xiuding Yang and Jiaxuan Li, to further enhance his research efforts and contribute to the scientific community.

Conclusion

Chenguan Liang's work exemplifies the importance of innovation in medicinal chemistry. His contributions, particularly through his patented pleuromutilin derivative, demonstrate the potential for developing effective treatments against pathogenic microorganisms. His ongoing research continues to pave the way for advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…